NAD+ 100 MG

NAD+ 100 mg – Peptide Hubs

Nicotinamide Adenine Dinucleotide (NAD+) is a coenzyme found in all living cells, playing a vital role in redox reactions, mitochondrial function, DNA repair, and energy metabolism. NAD+ levels decline with age, contributing to reduced cellular function and systemic fatigue. Peptide Hubs offers NAD+ in a high-purity, injectable 100 mg vial, suitable for scientific and metabolic research.

Mechanism of Action

NAD+ acts as a key coenzyme in oxidative phosphorylation and the Krebs cycle, enabling ATP production. It also serves as a substrate for sirtuins and PARPs—enzymes involved in DNA repair and epigenetic regulation. In aging models, restoring NAD+ levels has shown promising effects on mitochondrial health and cellular resilience. Refer to this NIH study on NAD+ and aging for more information.

Research Applications

• Cellular energy and mitochondrial performance studies
• Neurodegenerative and cognitive decline models
• DNA repair and oxidative stress response research
• Aging, sirtuin activation, and NAD salvage pathway modulation

NAD+ is often stacked with MOTS-c or Humanin in anti-aging and metabolic research protocols. For oxidative stress support, it pairs well with L-Glutathione, or with FOX04-DRI in senescence-related studies. Cognitive regeneration models often include N-Acetyl Semax Amidate to study NAD-linked BDNF pathways.

Suggested Experimental Use

• Dosage: 100–300 mg per week (e.g. 100 mg 2–3x weekly)
• Administration: Intravenous or intramuscular injection (research use)
• Duration: 4–8 weeks in cellular longevity and mitochondrial function studies

Stacking Recommendations

• MOTS-c – to synergize with NAD+ in mitochondrial optimization
• FOX04-DRI – for senescence and aging-related cell cycle arrest studies
• L-Glutathione – for redox support and DNA protection
• N-Acetyl Semax Amidate – for cognitive enhancement and neural NAD+ activation research

Safety & Legal Status

NAD+ is not FDA-approved and is available only for research use. It shows no evidence of androgenic, estrogenic, or hepatotoxic effects. It is well-tolerated in preclinical models. For related trials and updates, visit ClinicalTrials.gov.

Frequently Asked Questions